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ABSTRACT
The Purdue–University of Alabama Botanicals Research Center for
Age Related Disease joins novel technologies to study the bioavailabil-
ity of bioactive polyphenolic constituents and their relation to health.
Manydiseases thatmanifestwithagerelate tooxidativestressand tissue
damage. Our goal is to follow the fate of bioactive constituents from a
complex mixture to the organ affected by the disease and relate that to
a protective mechanism. Equally important is to screen commercially
available botanicals for their efficacy and safety. Botanicals and their
relation to bone antiresorptive capacity, cognitive function, vascular
effects, and cancer are principal themes in our center. Am J Clin
Nutr 2008;87(suppl):493S–7S.
KEY WORDS Botanicals, isoflavones, catechins, bone re-
sorption, cognitive function, cancer
INTRODUCTION
A multidisciplinary team and innovative approaches are
needed to identify and evaluate bioactive ingredients from com-
plex mixtures such as botanicals and to evaluate their health
benefits and mechanisms of action. The Purdue-UAB Botanicals
Research Center for Age Related Disease joins scientists from
Purdue University and the University of Alabama at Birmingham
with participation from the University of Illinois, Rutgers Uni-
versity, and the Indiana University School of Medicine. Scien-
tists with expertise in nutrition, plant physiology, horticulture,
pharmacy, veterinary medicine, physics, chemistry, statistics,
and medicine are part of our team. Our center targets age-related
diseases because many of them have an underlying etiology of
oxidative damage, and the polyphenolics in many botanicals
have potent antioxidant properties. The incidence of bone loss,
cognitive loss, hypertension, cardiovascular disease, type 2 dia-
betes, and stroke increases with age and dramatically in women
after menopause, and each of these components appears to be
related to some common mechanisms that synergize and thereby
accelerate morbidity and mortality. Because the use of estrogen
to offset these effects has been strongly questioned after the
findings of the Women’s Health Initiative, it is clear that a better
understanding of the basis for these postmenopausal symptoms
and their alleviation is needed. This brief overview presents
examples of studies conducted by the center to screen botanical
dietary supplements for their efficacy for bone anti-resorption
capacity in postmenopausal women, neuron protection in animal
models, anticancer potential in cell culture and animal models,
and vascular effects and glucose tolerance in animal models.
BIOAVAILABILITY OF BIOACTIVE COMPOUNDS
FROM COMPLEX MIXTURES
The study of individual or mixtures of compounds from com-
plex plant materials is a challenge. Our center is capitalizing on
several novel technologies developed or adapted by our investi-
gators that involve transferring samples from laboratory to lab-
oratory across institutions. The general plan is shown in Figure
1. Starting plant materials of interest are selected or produced in
a greenhouse at Rutgers University or the University of Illinois.
At the University of Illinois, 14C-enriched polyphenolics are
biosynthesized in plant cell suspension cultures or root cultures
grown in specially designed chambers as described for fla-
vonoids (1). Polyphenolics in the plants and fractions are char-
acterized at one of the several participating universities depend-
ing on the need. Crude extracts or fractions resulting from
vacuum liquid chromatography are transferred to Purdue Uni-
versity for animal studies. Rats receive fractions by gavage; and
pharmacokinetics, tissue distribution, and metabolism of 14C-
labeled or unlabeled bioactive compounds are followed in serum
or intestinal fluid from inserted membrane probes connected to a
programmable automatic sampling station machine developed at
Purdue Research Park (2). The biological samples are analyzed
for label by standard scintillation counting or for very low con-
centrations by accelerator mass spectrometry (AMS) at Purdue
University (3) or for polyphenols and metabolites by mass spec-
trometry at UAB. The ability of AMS to detect 14C with 1 
103–105 greater efficiency than liquid scintillation counting and
developments in mass spectrometry to measure femtomole quan-
tities in microliter samples allows absorption and transfer to
tissues to be characterized even for poorly absorbed compounds
and across the blood-brain barrier.
1 From Foods and Nutrition (CMW, DMM, and EMJ), Medicinal Chem-
istry and Molecular Pharmacology (DJM), and Food Science (MGF), Purdue
University, West Lafayette, IN; Pharmacology and Toxicology (SB, HK, and
JMW), University of Alabama, Birmingham, AL; Natural Resources and
Environmental Sciences (MAL), University of Illinois, Urbana, IL; and Plant
Biology and Pathology (JES), Rutgers University, New Brunswick, NJ.
2 Presented at the workshop “The Science of Botanical Supplements for
Human Health,” held at Experimental Biology 2007, Washington, DC, 28
April 2007.
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ISOFLAVONES AS BONE ANTIRESORPTIVE AGENTS
Several commercially available botanical dietary supplements
claim to be substitutes for estrogen therapy for preventing the
bone loss associated with menopause. Because the phytoestro-
gens in certain botanicals, including soy, red clover, and kudzu,
are chemically similar to estrogen and bind to the estrogen re-
ceptor, albeit weakly, much attention has been given to their
ability to attenuate the accelerated bone resorption associated
with estrogen deficiency accompanying menopause. A concern
has been raised that these bioactive compounds may affect re-
productive tissues similarly to estrogen (4). The barrier to eval-
uating effective interventions for preventing bone loss is that
bone has a very slow turnover rate and it takes several years to
properly monitor changes in bone mineral density, the classic
approach and the US Food and Drug Administration–approved
method. Thus, it is very expensive to measure dose-response
effects of a candidate therapy or to compare multiple interven-
tions.
Our center contributed to the development of a novel method
for rapidly and sensitively monitoring bone resorption by fol-
lowing 41Ca losses in urine from prelabeled bone measured by
AMS. Our study design screens multiple interventions per year in
the same subjects with the use of 50-d interventions administered
in a randomized, crossover design. Development of statistical
methods was also required to analyze data when 41Ca levels
change independent of treatment as bone remodels. We recently
reported the first intervention trial using 41Ca (5). A dose-
response study of soy protein containing 0–135.5 mg isofla-
vones/d showed no effect on bone resorption in postmenopausal
women. In contrast, estrogen therapy and a bisphosphate reduced
bone resorption with sufficient power to see significant effects in
4 and 6 women, respectively.
GRAPE SEED EXTRACT AND COGNITIVE FUNCTION
Botanical ingredients such as grape seed extract (GSE) en-
riched in proanthocyanidins (oligomeric polyphenols) had been
suggested to have multiple health benefits due to antioxidant and
other beneficial activities of the proanthocyanidin, but a system-
atic analysis of the molecular basis of these benefits has not been
done. Because the brain is particularly vulnerable to age-related
oxidative damage as well as inflammatory insults, we hypothe-
sized that ingestion of GSE would affect specific proteins in the
brains of animals in a manner consistent with neuroprotection.
We were the first to identify and quantify specific proteins in
mammalian tissues that were modulated by a dietary supplement
ingredient and were the first to demonstrate a link of ingesting
any complex botanical ingredient with any disease (6). Healthy
adult female rats were fed defined (AIN-76A; Teklad Diets,
Madison, WI) diets supplemented with 5% GSE (Kikkoman
Corporation, Chiba, Japan) for 6 wk. The brains were then re-
moved and the homogenates were subjected to proteomics anal-
ysis (two-dimensional electrophoresis and mass spectrometry).
Image and statistical analysis of the two-dimensional gel images
determined that 13 proteins were altered in amount, charge, or
both, which is qualitatively consistent with GSE being neuro-
protective. It is unknown whether the effects of GSE were due to
the polyphenols or their metabolites in the brain directly or in-
directly to the metabolism of endogenous compounds in the gut
FIGURE 1. Schematic of determining the bioavailability of bioactive polyphenolics from botanicals. Rel. Int., relative intensity.














during their enterohepatic circulation. Another possibility is reg-
ulation of signaling through the gut-brain axis via the nervous
system.
GREEN TEA AND CANCER PREVENTION
Epidemiologic and animal data support a potential role for tea
and tea catechins in the prevention of several chronic diseases,
including cancer, cardiovascular disorders, and obesity. Poor
oral bioavailability of catechins is believed to minimize the po-
tential efficacy of these tea polyphenols by limiting concentra-
tions at specific target tissues. Factors believed to contribute to
poor bioavailability of catechins include digestive instability,
poor transcellular efflux in intestinal cells, and rapid metabolism
and excretion (7). A further complication to understanding phys-
iologic catechin profiles is matrix effects associated with con-
sumption of tea. Adjuncts affecting catechin stability in food
systems are present in milk, juice, and antioxidants added to
beverages. We are using a coupled in vitro digestion Caco-2
intestinal cell culture model to evaluate digestive stability and
intestinal uptake of green tea catechins from various beverage
blends (8). Formulation affects the intestinal catechin profile; in
vivo investigations are underway on specific formulations that
positively influence catechin bioavailability.
Our center has studied the relation between green tea catechins
and cancer mediated through a cell surface protein, tNOX (Gen-
Bank accession no. AF207881) (9). tNOX appears to be a spe-
cific target for low-dose apoptosis of cancer cells by green tea
catechins (10), and its expression is restricted to cancer cells.
Cancer specificity resides in its expression of a splice variant (11)
that is uniquely drug inhibited and uniquely associated with
human cancer (9). When the tNOX of cancer cells is inhibited, the
cells fail to enlarge after division, cease to divide, and after a few
days undergo apoptosis.
The availability of a specific target provided a mechanism-
based approach to rapid evaluation and development of botani-
cals with anticancer activity. Key ameliorating polyphenols that
target tNOX were identified along with combinations based on
botanical sources that often duplicated the key ameliorating
polyphenols and interacted synergistically. Botanical prepara-
tions that most inhibited cancer cell growth involved synergies
between a decaffeinated green tea concentrate and vanilloid-
containing Capsicum preparations (Figure 2) (12). A 25:1 ratio
of green tea concentrate to Capsicum preparation killed cancer
cells in culture 100-times greater, by weight, than did green tea.
Assuming 2 g green tea per cup in preparing a usual green tea
infusion, our findings suggest that a 350-mg capsule of the com-
mercially available green tea extract–Capsicum preparations
(Capsibiol-T or Capsol-T; BND Service Company, West Union,
IL) is equivalent to drinking 16 cups of green tea on the basis of
the comparative responses of growth of 4T1 and HeLa cells in
culture (12). (-)-Epigallocatechin-3-gallate (EGCg), capsaicin,
vanillylamine, and green tea mixtures alone or combined with
vanilloids did not inhibit the growth of noncancer cell lines in
culture nor did they inhibit the activity of the corresponding NOX
protein constitutive to normal cells. This differential activity
suggests cancer specificity and safety of the green tea–Capsicum
mixtures. tNOX transfection and overexpression together with
antisense results showed that functional cell surface expression
of tNOX was both necessary and sufficient for the cancer-
specific inhibition of cell growth attributed to EGCg (13). As a
logical next step, transgenic mice overexpressing tNOX were
generated. By expressing the tNOX protein, transgenic animals
exhibited a level of unregulated cell enlargement and sensitivity
to EGCg similar to cancer cells. The transgenic mice experiments
provided an important test of the hypothesis that tNOX repre-
sents a necessary and sufficient molecular target as the basis for
the cancer therapeutic activity of EGCg (14).
In a series of open-label sequential trials, 36% of 50 cancer
participants with active cancer receiving Capsol-T had a signif-
icant prolongation of life or remained alive, 32% improved, and
the rest had a normal course of disease (15). A Phase II/III clinical
study (toxicology and pharmacokinetics) of Capsol-T with renal
cancer and melanoma directed by Theodore Logan at the Indiana
University School of Medicine is underway, and a more exten-
sive clinical study to evaluate efficacy is under development at
the Goshen Cancer Center, Goshen, IN. A favorable interaction
between a tea catechin–Capsicum preparation and radiation ther-
apy was previously indicated from compassionate intervention
studies with 5 cancer patients (16).
VASCULAR EFFECTS OF POLYPHENOLICS AND
INTERACTIONS WITH ANTIOXODANTS
Polyphenols in botanicals, including the bioflavonoids and
stilbenoids, have a role in regulating oxidative stress in cardio-
vascular disease and other chronic diseases of aging. These dis-
eases are marked by the production of reactive nitrogen species
(RNS), including peroxynitrite (ONOO) and nitrogen dioxide,
and reactive oxygen species (ROS), including superoxide, hy-
drogen peroxide, hypobromous acid, and hypochlorous acid
(HOCl), by eosinophils, macrophages, and neutrophils. Al-
though RNS and ROS modify DNA and proteins and disrupt
gene expression and protein function in targeted cells, they also
damage neighboring uninvolved normal cells. Because many of
the protein modifications are on tyrosine (3-nitrotyrosine,
FIGURE 2. Dose response of HeLa cells at 72 h in cell culture to a 25:1
decaffeinated green tea concentrate-Capsibiol-T mixture prepared on an
equivalent weight basis. Points are the mean  SD of 3–5 determinations.
Growth responses to mixture dilutions were analyzed by using a two-way
analysis of variance and were considered to be significant at P  0.05. One
350-mg capsule of Capsibiol-T is equivalent to drinking 16 cups of green tea.
Modified from Morré and Morré (12).














3-chlorotyrosine, and 3-bromotyrosine), an aromatic group, we
investigated how the RNS and ROS reacted with dietary poly-
phenols. In vitro, both HOCl and ONOO formed chloro and
nitro derivatives with the soy isoflavones daidzein and genistein
(17). These experiments were extended to incubation with acti-
vated neutrophil-like HL-60 cells (which produce HOCl when
stimulated with a phorbol ester) and freshly isolated human poly-
morphonuclear cells. In these studies, 90% of a bioflavonoid
(10 mol/L) in the medium was converted to chlorinated prod-
ucts within 30 min (18, 19). The nature of the chloro and nitro
derivatives was determined by 1H-NMR and liquid chromatog-
raphy–tandem mass spectrometry. The nitration occurred at the
3'-position in the phenolic B-ring as has been observed for ni-
trotyrosine in proteins. Chlorination was more complex, occur-
ring at the 6- and 8-positions on the A-ring of genistein and at the
3'-position in the B ring (20).
The isoflavones, as do other polyphenols, increase the lag time
for Cu2-induced oxidation of human LDL and reduce the prop-
agation rate of lipid peroxidation. However, their effect is weak.
We hypothesized that polyphenols undergo a cycle: they react
with lipid peroxide free radicals and are converted to free radicals
themselves. These attack new lipid molecules and restart the
process of lipid radical formation. Adding ascorbic acid in molar
excess to the reaction markedly improves overall antioxidant
activity to 2–3 times greater than the sum of the individual anti-
oxidant species (21). This is particularly relevant to the work
being carried out on the prevention of lens cataract disease.
Genistein administered in the diet enters the aqueous humor that
flows in front of the lens (22). Because the aqueous humor con-
tains 5–10 mmol ascorbic acid/L, the high ratio between ascorbic
acid and genistein may create a strong antioxidant environment.
It also suggests that the study of polyphenol effects in vivo has to
consider the whole botanical and not the individual components
(23).
Isoflavones, particularly genistein, prevent tumor necrosis
factor-–induced inhibition of the rolling of neutrophils to the
blood vessel wall in a flowing system (24). Intriguingly, chlori-
nation of daidzein and genistein reverses this protective effect
(25), which suggests that these products from the reaction of
isoflavones and HOCl have their own biological activities that
should not be ignored.
Polyphenols also appear to delay or partially prevent several
aspects of the metabolic syndrome, but the mechanisms under-
lying these effects remain to be elucidated. A model that dem-
onstrates these beneficial effects is in middle-aged, ovariecto-
mized spontaneously hypertensive rats, which are used as a
model for menopause, hypertension, insulin resistance, and
stroke. In these rats, administration of genistein and grape seed
extract independently blunts hypertension, and grape seed ex-
tract decreases cognitive decline. Recently, we have focused on
the effects of another polyphenol, puerarin, which is present in
kudzu root. Puerarin is a C-glucoside and in contrast with most
other polyphenols that are O-glucosides, puerarin does not re-
quire deglycosylation to cross from the intestines into the circu-
lating blood. This attribute has allowed us to track the kinetics,
sequestration, and elimination of this polyphenol (compared
with other polyphenols) with much greater accuracy.
In the initial long-term feeding studies, 3-mo-old female spon-
taneously hypertensive rats were fed casein-based AIN-76 diets
either containing 0.3% kudzu root extract or no polyphenols for
3 mo. Kudzu prevented 15  2 mm Hg of the 30  3 mm Hg
blood pressure rise that occurred in control (non-kudzu-treated)
rats. Heart rate was not affected by the treatment, but when the
ganglionic blocker hexamethonium was administered, the de-
crease in arterial pressure was significantly greater in the control
than in the treated rats, which suggests that sympathetic nervous
system activity is required to maintain the higher arterial pressure
in the control animals. Superoxide production was significantly
reduced in the kudzu-treated compared with the control animals
(Figure 3A). Kudzu root extract reduced resting blood glucose,
insulin, serum cholesterol, and leptin. Glucose tolerance and
glucose sensitivity were improved in the kudzu-supplemented
groups by 20%. Acute studies in rats and mice showed that
glucose tolerance was improved by 50% when puerarin and
glucose were administered simultaneously to otherwise naive
spontaneously hypertensive rats (26) (Figure 3B).
Safety assessment trials showed that kudzu root extract does
not cause adverse side effects in rats even when administered at
FIGURE 3. Effect of kudzu on superoxide anion formation and glucose
tolerance in spontaneously hypertensive rats. (A) In vitro measurement of
superoxide anion formation in aortic ring segments. The assay was calibrated
by monitoring the chemiluminescence signal of known amounts of superox-
ide generated by xanthine  xanthine oxidase (mean  SEM; * P  0.05 by
t test; n  5/group). (B) Dietary kudzu improved glucose tolerance in spon-
taneously hypertensive rats. Glucose was given by gavage (2 g glucose/kg)
at time 0. Note that the plasma glucose concentration was decreased by kudzu
extract treatment at all times (mean  SEM; P  0.05 for main effect of
treatment by one-way ANOVA; n  5/group).














1% of the diet for 2 mo. No treated or control animal showed
significant weight loss during the 3 mo feeding, but the rats on the
1.0% and 0.3% kudzu diets gained weight less rapidly than did
the rats on the 0.1% or 0.0% diets. No obvious pathology was
noted in any of the animals; blood pressure was reduced by 15
mm Hg, and heart rate was reduced by the 1.0% and 0.3% diets.
Thus, we have seen no adverse effects of the kudzu root extract
on the health of the animals.
To better understand the mechanisms by which kudzu root
extract affected health, we developed a highly sensitive mass
spectrometry method to assess puerarin in the body (27). Male
spontaneously hypertensive rats received a single-dose gavage
of puerarin (50 mg/kg body wt), and serial blood samples were
collected. The main pharmacokinetic parameters for puerarin
after oral administration were as follows: Cmax (3.54  2.03
mg/L), Tmax (0.68  0.37 h), AUC0-t (7.29  3.79 mg h/L),
AUC0- (9.17  4.87 mg h/L), T1/2 (1.7  0.6 h), CL/F (7.24 
4.27 L/h/kg), and V/F (17.88  13.55 L/h/kg), which indicates
that puerarin is rapidly absorbed into the blood and is relatively
rapidly cleared from the body. We also quantified puerarin in bile
and urine and body tissues by the use of liquid chromatography–
mass spectrometry/mass spectrometry. Intact puerarin was de-
tected in kidney, liver, lungs, pancreas, and eyes. Puerarin was
detected in bile samples within 10 min after oral administration.
Detection of puerarin in kidneys in a significant amount supports
the hypothesis that puerarin may inhibit the renal sodium-
dependent glucose transporter 2 and thereby decrease reabsorp-
tion of glucose to the blood.
CONCLUSIONS
Our center has used a multidisciplinary approach to develop a
model for studying the bioavailability of bioactive compounds
from complex mixtures. We have a long distance to go to make
this a routine procedure. Relating bioactive compounds in bo-
tanicals to the aging process and disease development through
multiple mechanisms presents great challenges but rewarding
opportunities.
CMW is on the advisory boards of Pharmavite and Wyeth. She receives
grant support from Wyeth and reviews research proposals for the United
Soybean Board. None of the other authors identified a potential conflict of
interest.
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